We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

Sandbox Reserved 1165

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 21: Line 21:
==How These Structures Lead to Function==
==How These Structures Lead to Function==
Structurally, the N-terminal extracellular domain (ECD) and the 7TM comprise the signature seven helical structure that is involved in signaling via coupling to heterotrimeric proteins that activate adenylate cyclase to increase the levels of intracellular cyclic AMP, and also heterotrimeric G proteins that increase inositol phosphate and intracellular calcium levels. The wider and deeper ligand-binding pocket of class B GPCRs allows for a vast array of receptors to be bound that allow for numerous functions activated by peptide receptors. The conformation and orientation of the 7TM and the ECD regions dictate the functionality of the protein.There is an open and closed conformation of the GCGR. When glucagon binds to GCGR, the open conformation of GCGR is stabilized. There is no clear binding site location of the hormone peptide ligand. They do know the N-terminus of glucagon binds deep into the binding pocket.The amino acids at the N-terminus have the ability to form hydrogen bonds and ionic interactions.
Structurally, the N-terminal extracellular domain (ECD) and the 7TM comprise the signature seven helical structure that is involved in signaling via coupling to heterotrimeric proteins that activate adenylate cyclase to increase the levels of intracellular cyclic AMP, and also heterotrimeric G proteins that increase inositol phosphate and intracellular calcium levels. The wider and deeper ligand-binding pocket of class B GPCRs allows for a vast array of receptors to be bound that allow for numerous functions activated by peptide receptors. The conformation and orientation of the 7TM and the ECD regions dictate the functionality of the protein.There is an open and closed conformation of the GCGR. When glucagon binds to GCGR, the open conformation of GCGR is stabilized. There is no clear binding site location of the hormone peptide ligand. They do know the N-terminus of glucagon binds deep into the binding pocket.The amino acids at the N-terminus have the ability to form hydrogen bonds and ionic interactions.
-
[[Image:Amino_Acid_Sequence.jpg|(|):|300 px|right|Amino Acid Sequence of Glucagon]]
+
[[Image:Amino_Acid_Sequence.jpg|(|):|300 px|right|Amino Acid Sequence of Glucagon]]
 +
Many of the residues that are in direct contact with the glucagon molecule are charged or are polar.
 +
There are also any bulk resides on glucagon that support the bulky resides on the GCGR. These residues are located within the binding pocket of the 7TM. There are specific amino acid interactions that hold the helices of the 7TM in the conformation that maximizes affinity, this includes a disulfide bond between Cys 294 and Cys 224 that serves to hold the ECL1 and ECL2 in the proper orientation.Also, the salt bridges between Glu 406, Arg 173, and Arg 346 that hold the conformation of affinity. Alpha helical structure of the stalk is imperative to the affinity and binding of the glucagon.
 +
 
 +

Revision as of 12:41, 22 March 2016

[[Image:]]

This Sandbox is Reserved from Jan 11 through August 12, 2016 for use in the course CH462 Central Metabolism taught by R. Jeremy Johnson at the Butler University, Indianapolis, USA. This reservation includes Sandbox Reserved 1160 through Sandbox Reserved 1184.
To get started:
  • Click the edit this page tab at the top. Save the page after each step, then edit it again.
  • Click the 3D button (when editing, above the wikitext box) to insert Jmol.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Human Glucagon Class B G Protein-Coupled Receptors (GPCRs)

Class B 7TM

Drag the structure with the mouse to rotate

Clinical Relevancy

Of the fifteen human class B GPCRs, eight have been identified as potential drug target. Therapeutic agents have been created from the peptides themselves within this protein, but overall pharmaceutical companies have had difficulty creating agents that act on family B GPCRS. There is an outward appearance and inherent flexibility in the class B GCGR 7TM because of conserved hydrogen bonds that flank a glycine residue, and this structure along with the ECD and its role of interactions on the extracellular side of receptors may provide evidence to how class B receptors adjust its conformational spectra for various receptors. Researchers hope to show how these conformations can be utilized in potential treatments of a wide array disorders.

References

Personal tools